NCT00154336 - A Study of Imatinib 400 mg Once Daily in Combination With Methotrexate in the Treatment of Rheumatoid Arthritis. | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 31, 2004

Primary Completion Date

August 31, 2005

Study Completion Date

August 31, 2005

Conditions

Rheumatoid Arthritis

Interventions

DRUG

Imatinib

DRUG

Methotrexate

DRUG

Imatinib Placebo

Trial Locations (15)

8036

Novartis Investigative site, Graz

A-1090

Novartis Investigative site, Vienna

A-1130

Novartis Investigative site, Vienna

R3A 1M1

Novartis Investigative site, Winnipeg

M5G 1X5

Novartis Investigative site, Toronto

H3Z 2Z3

Novartis Investigative site, Montreal

G1W 4R4

Novartis Investigative site, Sainte-Foy

00260

Novartis Investigative site, Helsinki

00029

Novartis Investigative site, Husu

WS11 2XY

Novartis Investigative site, Cannock

CO4 5JL

Novartis Investigative site, Colchester

G11 6NT

Novartis Investigative site, Glasgow

M41 5SL

Novartis Investigative site, Manchester

Unknown

Multiple Sites, Multiple Cities

ST6 7AG

Novartis Investigative site, Stoke-on-Trent